Live Breaking News & Updates on Are Significantly Lower

Stay updated with breaking news from Are significantly lower. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Semaglutide Beneficial in HFpEF Patients With Diabetes

In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial. ....

United States , Mikhailn Kosiborod , Bethl Abramson , Clinical Research , American College Of Cardiology , University Of Toronto , Luke Health System , Health System , Kansas City , Study Entry , Featured Clinical Research , American College , New England Journal , Are Significantly Lower , Heart Failure , Weight Loss , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Weight Management , Quality Of Life , Ealth Related Quality Of Life , Cardiovascular Imaging , Ardiac Imaging , V Imaging ,